GSEP
OGN icon

Golden State Equity Partners’s Organon & Co OGN Stock Holding History

Golden State Equity Partners’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-379
Closed -$2.27K – 1283
2026
Q1 		$2.27K Buy
+379
New +$2.85K ﹤0.01% 1649
2024
Q4 		– Sell
-4
Closed -$76 – 734
2024
Q3 		$76 Buy
+4
New +$83 ﹤0.01% 906

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Golden State Equity Partners's OGN Position: Q2 2026 in Review

Golden State Equity Partners sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 379 shares — an estimated $2.27K sold.

Golden State Equity Partners first reported a position in OGN in Q3 2024 and held it in 2 quarters. The position peaked at $2.27K in Q1 2026. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Golden State Equity Partners reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 379 Organon & Co shares in Q2 2026, an estimated $2.27K.
  • Golden State Equity Partners first reported a position in Organon & Co in Q3 2024 and held it in 2 quarters.
  • Golden State Equity Partners's Organon & Co position peaked at $2.27K in Q1 2026.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.